The power of HLA-G +3142G/C genetic variants to predict the metastatic-free survival among breast cancer patients was investigated by comparing patients carrying no risk allele (GG) versus those carrying at least one risk allele (CC and CG) (Figure 4). This evidence concerns the gene HLA-G and breast carcinoma.